HomeCompareVRRMW vs JNJ

VRRMW vs JNJ: Dividend Comparison 2026

VRRMW yields 26.53% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRRMW wins by $77.8K in total portfolio value
10 years
VRRMW
VRRMW
● Live price
26.53%
Share price
$7.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$108.1K
Annual income
$12,843.31
Full VRRMW calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — VRRMW vs JNJ

📍 VRRMW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRRMWJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRRMW + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VRRMW pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRRMW
Annual income on $10K today (after 15% tax)
$2,254.64/yr
After 10yr DRIP, annual income (after tax)
$10,916.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, VRRMW beats the other by $6,930.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRRMW + JNJ for your $10,000?

VRRMW: 50%JNJ: 50%
100% JNJ50/50100% VRRMW
Portfolio after 10yr
$69.2K
Annual income
$8,766.36/yr
Blended yield
12.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VRRMW
No analyst data
Altman Z
1.3
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRRMW buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRRMWJNJ
Forward yield26.53%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$108.1K$30.3K
Annual income after 10y$12,843.31$4,689.40
Total dividends collected$70.2K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VRRMW vs JNJ ($10,000, DRIP)

YearVRRMW PortfolioVRRMW Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,353$2,652.52$10,592$272.30+$2.8KVRRMW
2$17,597$3,310.08$11,289$357.73+$6.3KVRRMW
3$22,906$4,076.96$12,123$472.89+$10.8KVRRMW
4$29,469$4,959.72$13,141$629.86+$16.3KVRRMW
5$37,495$5,963.37$14,408$846.81+$23.1KVRRMW
6$47,211$7,091.17$16,021$1,151.60+$31.2KVRRMW
7$58,861$8,344.52$18,122$1,588.22+$40.7KVRRMW
8$72,704$9,722.92$20,930$2,228.20+$51.8KVRRMW
9$89,017$11,223.93$24,792$3,191.91+$64.2KVRRMW
10$108,091$12,843.31$30,274$4,689.40+$77.8KVRRMW

VRRMW vs JNJ: Complete Analysis 2026

VRRMWStock

Verra Mobility Corporation provides smart mobility technology solutions and services in the United States, Australia, Canada, and Europe. It operates through three segments: Commercial Services; Government Solutions; and Parking Solutions. The Government Solutions segment offers automated safety solutions, including services and technologies that enable photo enforcement through road safety camera programs, which detects and process traffic violations related to red light, speed, school bus, and city bus lanes. This segment serves municipalities, counties, school districts, and law enforcement agencies. The Commercial Services segment provides automated toll and violations management, and title and registration services to rental car companies, fleet management companies, and other large fleet owners. The Parking Solutions segment provides an integrated suite of parking software and hardware solutions to universities, municipalities, parking operators, healthcare facilities, and transportation hubs. The company was incorporated in 2016 and is headquartered in Mesa, Arizona.

Full VRRMW Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VRRMW vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRRMW vs SCHDVRRMW vs JEPIVRRMW vs OVRRMW vs KOVRRMW vs MAINVRRMW vs ABBVVRRMW vs MRKVRRMW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.